Robert Barrie, Author at Clinical Trials Arena https://www.clinicaltrialsarena.com/author/rbarrie/ Hard data and deep insights on clinical trials strategy & operations Fri, 08 Nov 2024 16:09:16 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/cropped-Clinical-Trials-Arena-32x32.png Robert Barrie, Author at Clinical Trials Arena https://www.clinicaltrialsarena.com/author/rbarrie/ 32 32 Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment https://www.clinicaltrialsarena.com/news/hurricane-helene-delays-spectral-medicals-confirmatory-trial-enrolment/ Fri, 08 Nov 2024 15:56:38 +0000 https://www.clinicaltrialsarena.com/uncategorized/hurricane-helene-delays-spectral-medicals-confirmatory-trial-enrolment/ Spectral aims to finalise enrolment in early 2025 for its septic shock treatment Toraymyxin.

The post Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment appeared first on Clinical Trials Arena.

]]> The post Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment appeared first on Clinical Trials Arena.

]]> Penumbra reveals positive data for algorithm-assisted thrombectomy tech https://www.clinicaltrialsarena.com/news/penumbra-reveals-positive-data-for-algorithm-assisted-thrombectomy-tech/ Wed, 06 Nov 2024 16:29:20 +0000 https://www.clinicaltrialsarena.com/uncategorized/penumbra-reveals-positive-data-for-algorithm-assisted-thrombectomy-tech/ Penumbra’s catheter was compared to other standard procedures in a 2,060 patient-strong analysis.

The post Penumbra reveals positive data for algorithm-assisted thrombectomy tech appeared first on Clinical Trials Arena.

]]> The post Penumbra reveals positive data for algorithm-assisted thrombectomy tech appeared first on Clinical Trials Arena.

]]> Abbott touts long-term efficacy for dissolvable Esprit BTK stent https://www.clinicaltrialsarena.com/news/abbott-touts-long-term-efficacy-for-dissolvable-esprit-btk-stent/ Tue, 05 Nov 2024 16:50:01 +0000 https://www.clinicaltrialsarena.com/uncategorized/abbott-touts-long-term-efficacy-for-dissolvable-esprit-btk-stent/ Approximately 90% of severe PAD patients with the stent did not require a reintervention at 24 months.

The post Abbott touts long-term efficacy for dissolvable Esprit BTK stent appeared first on Clinical Trials Arena.

]]> The post Abbott touts long-term efficacy for dissolvable Esprit BTK stent appeared first on Clinical Trials Arena.

]]> Onward raises $54m to continue neuromodulation trials https://www.clinicaltrialsarena.com/news/onward-raises-54m-to-continue-neuromodulation-trials/ Thu, 24 Oct 2024 15:13:03 +0000 https://www.clinicaltrialsarena.com/uncategorized/onward-raises-54m-to-continue-neuromodulation-trials/ Germany-based Ottobock SE & Co. KGaA will hold an approximate 10% stake in Onward’s share capital following the investment.

The post Onward raises $54m to continue neuromodulation trials appeared first on Clinical Trials Arena.

]]> The post Onward raises $54m to continue neuromodulation trials appeared first on Clinical Trials Arena.

]]> Oxford Medical Products touts positive safety data for ‘mechanical’ weight loss pill https://www.clinicaltrialsarena.com/news/oxford-medical-products-touts-positive-safety-data-for-mechanical-weight-loss-pill/ Tue, 22 Oct 2024 16:02:31 +0000 https://www.clinicaltrialsarena.com/uncategorized/oxford-medical-products-touts-positive-safety-data-for-mechanical-weight-loss-pill/ The company is eyeing a pivotal trial for its dual-polymer hydrogel stomach implant following promising first-in-human trial data.

The post Oxford Medical Products touts positive safety data for ‘mechanical’ weight loss pill appeared first on Clinical Trials Arena.

]]> The post Oxford Medical Products touts positive safety data for ‘mechanical’ weight loss pill appeared first on Clinical Trials Arena.

]]> Endospan hits enrolment milestone in aortic arch stent trial              https://www.clinicaltrialsarena.com/news/endospan-hits-enrolment-milestone-in-aortic-arch-stent-trial/ Mon, 21 Oct 2024 13:45:03 +0000 https://www.clinicaltrialsarena.com/uncategorized/endospan-hits-enrolment-milestone-in-aortic-arch-stent-trial/ Endospan is advancing as US trial as it looks to gain FDA approval for its already CE marked device.

The post Endospan hits enrolment milestone in aortic arch stent trial              appeared first on Clinical Trials Arena.

]]> The post Endospan hits enrolment milestone in aortic arch stent trial              appeared first on Clinical Trials Arena.

]]> Mixed results for Nexalin’s transcranial alternating current stimulation trial https://www.clinicaltrialsarena.com/news/mixed-results-for-nexalins-transcranial-alternating-current-stimulation-trial/ Fri, 18 Oct 2024 14:53:53 +0000 https://www.clinicaltrialsarena.com/uncategorized/mixed-results-for-nexalins-transcranial-alternating-current-stimulation-trial/ Nexalin’s device missed the primary endpoint but produced positive data in secondary endpoint measures.

The post Mixed results for Nexalin’s transcranial alternating current stimulation trial appeared first on Clinical Trials Arena.

]]> The post Mixed results for Nexalin’s transcranial alternating current stimulation trial appeared first on Clinical Trials Arena.

]]> Bavarian Nordic’s mpox vaccine equally effective in teens as adults https://www.clinicaltrialsarena.com/news/bavarian-nordics-mpox-vaccine-equally-effective-in-teens-as-adults/ Thu, 17 Oct 2024 16:58:34 +0000 https://www.clinicaltrialsarena.com/uncategorized/bavarian-nordics-mpox-vaccine-equally-effective-in-teens-as-adults/ Bavarian Nordic’s MVA-BN vaccine showed equivalent antibody response and safety between teenagers and adults in an NIH study.

The post Bavarian Nordic’s mpox vaccine equally effective in teens as adults appeared first on Clinical Trials Arena.

]]> The post Bavarian Nordic’s mpox vaccine equally effective in teens as adults appeared first on Clinical Trials Arena.

]]> J&J makes surgical robotic moves with Ottava FDA IDE application https://www.clinicaltrialsarena.com/news/jj-makes-surgical-robotic-moves-with-ottava-fda-ide-application/ Wed, 16 Oct 2024 14:48:36 +0000 https://www.clinicaltrialsarena.com/uncategorized/jj-makes-surgical-robotic-moves-with-ottava-fda-ide-application/ After a two-year delay, J&J is ready to disrupt Intuitive’s market domination with Da Vinci.

The post J&J makes surgical robotic moves with Ottava FDA IDE application appeared first on Clinical Trials Arena.

]]> The post J&J makes surgical robotic moves with Ottava FDA IDE application appeared first on Clinical Trials Arena.

]]> Microbot eyes FDA application for surgical robot after completing pivotal trial https://www.clinicaltrialsarena.com/news/microbot-eyes-fda-application-for-surgical-robot-after-completing-pivotal-trial/ Tue, 15 Oct 2024 14:21:25 +0000 https://www.clinicaltrialsarena.com/uncategorized/microbot-eyes-fda-application-for-surgical-robot-after-completing-pivotal-trial/ The US robotics company is ramping up its go-to-market strategy ahead of potential FDA clearance in Q2 2025.

The post Microbot eyes FDA application for surgical robot after completing pivotal trial appeared first on Clinical Trials Arena.

]]> The post Microbot eyes FDA application for surgical robot after completing pivotal trial appeared first on Clinical Trials Arena.

]]>